Arteriosclerosis Clinical Trial
Official title:
Mindfulness-Based Stress Reduction and Myocardial Ischemia
The principal objective of the study is to evaluate the effectiveness of a widely used
complementary medicine intervention, mindfulness-based stress reduction (MBSR), in which
mindfulness meditation and yoga are the principal components in the treatment of a chronic,
often fatal illness that affects tens of millions of Americans. The investigators propose to
conduct a single center randomized controlled trial in which 150 patients will be assigned
to either a mindfulness meditation condition, a disease education control condition, or a
stress-monitoring usual care control condition. They will test the following specific
hypotheses:
1. In comparison to either of the control conditions, significantly more coronary artery
disease (CAD) patients in the mindfulness meditation condition will demonstrate
reductions in mental stress-induced ischemia.
2. The ratio of low-to-high frequency of spectral power in heart rate variability during
ambulatory monitoring will be significantly decreased following the participation in a
stress reduction program compared with those in a disease education or usual care
condition.
3. Patients in the mindfulness meditation condition will report greater improvement in
quality of life (i.e., reductions in general psychological symptomology, anger,
anxiety, depression, and daily stress, along with increases in optimism and stress
coping efficacy) than patients in either of the control conditions.
4. Day-to-day variability in self-reported mental stress will be inversely related to
day-to-day stress coping efficacy in the entire sample and time spent in mindfulness
practice in the active treatment condition, and these relationships will be maintained
over a 3-month follow-up.
5. Patients with CAD and mental stress ischemia who show an *abnormal peripheral artery
response during baseline studies will show a significant improvement after mindfulness
intervention.
- Abnormal responses will be defined as peripheral arterial tonometry (PAT) tracings
that decrease greater than 20% in amplitude during mental stress.
BACKGROUND:
Acute and chronic psychological stress has been shown to be a risk factor for cardiac
events. More recently with the advent of new technology allowing cardiac imaging, acute
psychological stressors have been shown to produce myocardial ischemia in certain subsets of
patients with CAD. Several studies have shown that the production of myocardial ischemia in
response to acute psychological stress in the laboratory is a marker for adverse events in
patients with CAD. Several pathways by which psychologically induced stress may trigger
ischemic events have been proposed, and a number of studies have provided evidence that
stress affects ischemic events via these pathways. Stress interventions have been shown to
have a positive impact on CAD outcomes, with only one thus far testing their effects on
ischemic events. Furthermore, some studies have reported positive results with coronary risk
factors using meditation and yoga. Current clinical meditation literature suggests that a
mindfulness meditation-based stress reduction program (i.e., multicomponent,
psychoeducational program based in mindfulness meditation that cultivates an ability to pay
attention to one's moment-to-moment experiences in a nonjudgmental, nonreactive fashion)
will be able to reduce stress reactivity in CAD patients. It is predicted that such
reductions in stress reactivity will result in reduced radionuclide imaged perfusion defects
during a laboratory mental stress task. Although it has not been used with heart patients,
it has demonstrated good results with both stress and symptomology in the general and other
medical populations. We believe that similar results will be seen in CAD patients with
effects acting through the following pathways: 1) decreased sympathetic tone and 2)
increased parasympathetic tone. The overall goal of the proposed study is to evaluate the
efficacy of a meditation-based stress reduction program for the reduction of mental
stress-induced ischemia.
DESIGN NARRATIVE:
To test the efficacy of MBSR, patients will be randomly assigned to one of three groups. The
MBSR condition will be provided training in mindfulness meditation methods. The patient
education control group will be provided information about CAD in a didactic format. This
condition will control for the nonspecific effects of contact in a therapeutic setting.
Excluding intervals spent in personal meditation practice in the mindfulness meditation
condition, the length of sessions in the two intervention conditions will be approximately
equal. The third group, a stress-monitoring usual care control condition, will control for
the effects of symptom measurement reactivity in patients receiving routine medical care.
;
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Not yet recruiting |
NCT02866656 -
The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion(ASO) Syndrome
|
N/A | |
Completed |
NCT02510547 -
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
|
Phase 4 | |
Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
Completed |
NCT01334268 -
RESOLUTE China RCT
|
N/A | |
Active, not recruiting |
NCT00154180 -
Kronos Early Estrogen Prevention Study (KEEPS)
|
Phase 4 | |
Recruiting |
NCT04343209 -
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
|
||
Not yet recruiting |
NCT06039748 -
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
|
||
Recruiting |
NCT04142021 -
Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
|
||
Recruiting |
NCT06008756 -
MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
|
Phase 3 | |
Completed |
NCT03253692 -
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
|
||
Active, not recruiting |
NCT04624854 -
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
|
Phase 4 | |
Active, not recruiting |
NCT02921230 -
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
|
N/A | |
Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
Terminated |
NCT01462721 -
The eSVS® Mesh Randomized Post-Market Study
|
N/A | |
Completed |
NCT01455974 -
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
|
N/A | |
Completed |
NCT01221610 -
BIOLUX P-I First in Man Study
|
N/A | |
Active, not recruiting |
NCT00863967 -
Early Detection of Arteriosclerosis
|
N/A | |
Active, not recruiting |
NCT00174902 -
The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
|
Phase 1/Phase 2 | |
Completed |
NCT00050817 -
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
|
Phase 3 |